1. Home
  2. TKLF vs NRSN Comparison

TKLF vs NRSN Comparison

Compare TKLF & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TKLF

Yoshitsu Co. Ltd

BUY

Current Price

$1.50

Market Cap

8.3M

ML Signal

BUY

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

SELL

Current Price

$3.98

Market Cap

14.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TKLF
NRSN
Founded
2006
2017
Country
Japan
Israel
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
14.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
TKLF
NRSN
Price
$1.50
$3.98
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $97.33
AVG Volume (30 Days)
8.2K
★ 124.8K
Earning Date
07-10-2026
09-25-2026
Dividend Yield
★ 15.87%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.82
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.43
$0.25
52 Week High
$3.77
$7.50

Technical Indicators

Market Signals
Indicator
TKLF
NRSN
Relative Strength Index (RSI) 30.88 51.49
Support Level N/A $0.63
Resistance Level $2.43 $7.50
Average True Range (ATR) 0.09 0.85
MACD -0.01 -0.37
Stochastic Oscillator 18.08 10.58

Price Performance

Historical Comparison
TKLF
NRSN

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, electronic products, and other products. It sells its products through directly operated physical stores, online stores, and franchise stores and wholesale customers. It operates through directly operated physical stores, online stores and services, and franchise stores and wholesale customers segments, with the franchise stores and wholesale customers segment generating maximum revenue. Geographically, it generates maximum revenue from Hong Kong.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: